Profile picture

Doctor Fawaz Alenezi

Duke University School of Medicine, Durham (United States of America)
Follow
Logo ESC

Contributor content

What is the incidence of heart failure with preserved ejection fraction (HFpEF) versus heart failure with reduced ejection fraction (HFrEF) in breast cancer survivors compared to non-cancer controls?
Journal
What is the incidence of heart failure with preserved ejection fraction (HFpEF) versus heart failure with reduced ejection fraction (HFrEF) in breast cancer survivors compared to non-cancer controls?
3 August 2026
See more
Atrial fibrillation is an independent determinant of mortality and resource utilisation in hospitalised multiple myeloma patients
Journal
Atrial fibrillation is an independent determinant of mortality and resource utilisation in hospitalised multiple myeloma patients
3 August 2026
See more
What are the trends and in-hospital outcomes of catheter ablation for atrial fibrillation in patients with myeloproliferative neoplasms?
Journal
What are the trends and in-hospital outcomes of catheter ablation for atrial fibrillation in patients with myeloproliferative neoplasms?
3 August 2026
See more
What are the trends and outcomes of transcatheter aortic valve replacement (TAVR) in patients with myeloproliferative neoplasms compared to matched controls?
Journal
What are the trends and outcomes of transcatheter aortic valve replacement (TAVR) in patients with myeloproliferative neoplasms compared to matched controls?
3 August 2026
See more
Outcomes and predictors of mortality in patients with acute leukemia undergoing percutaneous coronary intervention (PCI) : a 7-year U.S analysis
Journal
Outcomes and predictors of mortality in patients with acute leukemia undergoing percutaneous coronary intervention (PCI) : a 7-year U.S analysis
3 August 2026
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources